regulatory
confidence high
sentiment neutral
materiality 0.70
Opy Acquisition Corp. I: Nasdaq/NYSE listing notice — OPY Acquisition Corp I receives Nasdaq MVLS deficiency notice; Sponsor exchanges 3.16M shares to regain compliance
Opy Acquisition Corp. I
- On Apr 3, 2023, Nasdaq notified company that MVLS was under $50M for 30 consecutive days; 180-day cure period until Oct 2, 2023.
- On Apr 10, Sponsor exchanged 3,162,499 Founders Shares into Class A common; pro forma MVLS increase ~$32M based on $10.22 close.
- To regain compliance, MVLS must be >= $50M for 10 consecutive trading days and Nasdaq must provide written confirmation.
- If compliance not regained by Oct 2, securities subject to delisting; company may appeal to Hearings Panel.
- No assurance that the exchange will allow regaining compliance with MVLS Rule.